Ticker brief
SDGR
last close
·
1 day
·
14 days
·
mkt cap
·
signals 14d
47
authors 14d
25
crowd 14d
-0.5σ
No price history on file for this name (likely non-equity or unlisted) — the “since then” column below stays blank.
Sentiment — last 14 days
daily mean sentiment, 2026-10-02 → 2026-10-16 · now +0.40 (−1 bearish … +1 bullish)
Who spoke25
| author | grade | trader score | signals | mean sent |
|---|---|---|---|---|
| @Omnitrader69 | C | -2.17 | 4 | +0.33 |
| @MartyChargin | C | -0.56 | 4 | -0.05 |
| @zohmbastic | C | -2.94 | 4 | +0.44 |
| @kulturdesken | B | +0.49 | 4 | +0.76 |
| @cnfinancewatch | B | -1.23 | 4 | +0.53 |
| @BornInvestor | C | -1.00 | 3 | +0.13 |
| @fundmyfund | B | -0.41 | 2 | -0.15 |
| @cfromhertz | B | -0.96 | 2 | +0.40 |
| @thesetupfactory | B | -2.36 | 2 | +0.55 |
| @beach_trades | C | -2.97 | 2 | +0.33 |
| @Pablo01618 | A | -0.56 | 2 | +0.45 |
| @OpenOutcrier | C | · | 1 | +0.45 |
| @RichardMoglen | B | +0.15 | 1 | +0.50 |
| @OptionsFlowBoss | C | · | 1 | +0.50 |
| @1ChartMaster | C | -2.95 | 1 | +0.65 |
| @BoxTraderVK | C | -0.97 | 1 | +0.75 |
| @spluscollective | C | -0.98 | 1 | +0.80 |
| @nextbigtrade | B | -1.29 | 1 | +0.70 |
| @Stevendiaz | B | -0.49 | 1 | -0.45 |
| @SayNoToTrading | A | -0.55 | 1 | -0.40 |
| @nft_hu | A | -1.38 | 1 | +0.25 |
| @Biotech2k1 | A | +1.11 | 1 | -0.75 |
| @MMatters22596 | C | -0.73 | 1 | +0.50 |
| @OracleNYSE | C | +0.83 | 1 | +0.30 |
| @ye4yn | B | -0.66 | 1 | -0.70 |
Recent signals30of 47 in 14d — receipts included
| date (PT) | author | sent | what they said | since then | receipt |
|---|---|---|---|---|---|
| 2026-10-16 | @zohmbastic | +0.40 | KeyBanc raised SDGR's target to $32 from $20 while maintaining Overweight. | · | tweet ↗ |
| 2026-10-15 | @beach_trades | +0.35 | Forecasts SOPH will soon lead the AI-biotech group alongside three peers. | · | tweet ↗ |
| 2026-10-13 | @zohmbastic | +0.40 | TD Cowen raised Schrodinger's target to $31 from $20 and retained Buy. | · | tweet ↗ |
| 2026-10-13 | @Pablo01618 | +0.25 | Presents a three-year biosimulation thesis centered on CERT, with SDGR as a peer platform. | · | tweet ↗ |
| 2026-10-12 | @MartyChargin | -0.70 | Mocks SDGR's continued lower lows and deteriorating chart. | · | tweet ↗ |
| 2026-10-12 | @zohmbastic | +0.40 | BMO raised Schrodinger's target to $30 from $24 and retained Outperform. | · | tweet ↗ |
| 2026-10-12 | @ye4yn | -0.70 | Exit SDGR and SOPH, reduce COPX, and add SNOW and later KEYS. — Explicit rebalance orders pair exits and a reduction with additions to higher-ranked holdings. | · | tweet ↗ |
| 2026-10-11 | @cnfinancewatch | +0.55 | Presents SDGR and RXRX as leading public-market AI-drug-discovery infrastructure candidates. | · | tweet ↗ |
| 2026-10-11 | @cnfinancewatch | +0.55 | Ranks three listed companies as candidate infrastructure platforms for AI-enabled drug discovery. | · | tweet ↗ |
| 2026-10-10 | @cnfinancewatch | +0.55 | Selects three listed firms as leading AI-drug-discovery infrastructure candidates while warning platform outcomes remain risky. | · | tweet ↗ |
| 2026-10-09 | @OracleNYSE | +0.30 | White House agencies announced a $1.8B Biohub partnership for AI-ready biological data. | · | tweet ↗ |
| 2026-10-09 | @MartyChargin | +0.25 | Says SDGR is beginning to rebound after a weak week. | · | tweet ↗ |
| 2026-10-08 | @kulturdesken | +0.85 | Triple the SDGR position. — Explicitly directs a substantial increase in SDGR exposure. | · | tweet ↗ |
| 2026-10-08 | @cnfinancewatch | +0.45 | Presents a long-term biotech growth basket spanning genomics, AI drug discovery and related platforms. | · | tweet ↗ |
| 2026-10-07 | @MMatters22596 | +0.50 | Presents a long-term biotech basket organized by genomics and AI drug-discovery layers. | · | tweet ↗ |
| 2026-10-07 | @Biotech2k1 | -0.75 | Calls AI-linked and vaccine biotech names overhyped meme stocks reminiscent of the genomics bubble. | · | tweet ↗ |
| 2026-10-06 | @fundmyfund | -0.60 | Strongly condemns SDGR's price action. | · | tweet ↗ |
| 2026-10-06 | @nft_hu | +0.25 | Maps public companies to seven stages of AI-assisted drug development. | · | tweet ↗ |
| 2026-10-06 | @MartyChargin | -0.60 | Uses a falling-chart emoji and joke to characterize a bad day for SDGR. | · | tweet ↗ |
| 2026-10-06 | @Pablo01618 | +0.65 | Added SDGR and bought out the long end of existing spreads. — Explicitly adds SDGR during an 11% dip and adjusts existing spread exposure. | · | tweet ↗ |
| 2026-10-06 | @kulturdesken | +0.70 | Adding more SDGR. — Briefly states an intention or action to acquire more SDGR. | · | tweet ↗ |
| 2026-10-06 | @BornInvestor | -0.35 | Reports SDGR weakness as biotech and drug-discovery stocks are sold. | · | tweet ↗ |
| 2026-10-06 | @kulturdesken | +0.75 | Buy more SDGR if it turns up at a short-term pivot. — Reports adding SDGR and states a conditional plan to buy more on a bullish pivot. | · | tweet ↗ |
| 2026-10-06 | @kulturdesken | +0.75 | Views headline-driven biotech selling as an opportunity and identifies SDGR as the focus. | · | tweet ↗ |
| 2026-10-06 | @SayNoToTrading | -0.40 | Identifies medtech-AI and genomics names dominating the day's losers amid company-specific events. | · | tweet ↗ |
| 2026-10-06 | @Omnitrader69 | -0.20 | Reports being stopped at 31 and discusses an unmaterialized buyout, while only tentatively considering re-entry. | · | tweet ↗ |
| 2026-10-06 | @Stevendiaz | -0.45 | Finds these biotech names difficult to invest in due to cash burn and minimal revenue. | · | tweet ↗ |
| 2026-10-05 | @beach_trades | +0.30 | Expects SOPH to be the next AI-biotech name to make large upward moves. | · | tweet ↗ |
| 2026-10-05 | @nextbigtrade | +0.70 | Calls SDGR a monster stock with four consecutive weeks of high volume and favorable sector exposure. | · | tweet ↗ |
| 2026-10-05 | @spluscollective | +0.80 | Holding SDGR with IPO anchored VWAP as the target. — Expresses continued bullish holding conviction and names IPO anchored VWAP as the target. | · | tweet ↗ |
“Since then” = price move from the close on the signal's date (PT) to the latest close — what happened after they said it, not a backtest. A — means no trading session has closed since the signal yet. Sentiment is our extracted per-tweet score, −1…+1.